₹ 601.80
4.60 (0.77%)
C
Concord Biotech
₹ 601.80
Concord Biotech Share Price Today
Concord Biotech (CONCORDBIO) share price is trading at ₹601.80 on the NSE as of November 12, 2026 at 03:57 PM, up by 0.77% from its previous close of ₹597.20. In todays trading session CONCORDBIO reached a high of 604.40 and low of 595.80. The average traded price for today is 600.25. The 50 DMA stands at 683.60 and 200 DMA is at 632.08. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : CONCORDBIO
- Open : ₹600.00
- Previous Close : ₹597.20
- Day's Range : ₹595.80 – ₹604.40
- 52-Week Range : ₹493.50 – ₹807.50
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
CONCORDBIO Stock Performance
Markets Today
High
604.40
Low
595.80
Open at
600.00
Prev Close
597.20
Volumes
1,96,543
Avg Price
600.25
Lower Circuit
481.50
Upper Circuit
722.10
Last Traded Details
Quantity
20
Time
15:57:02
Price Movement
Historical Performance
3 M High
807.50
3 M Low
578.00
1 Yr High
807.50
1 Yr Low
493.50
3 Yr High
1,332.00
3 Yr Low
493.50
5 Yr High
1,332.00
5 Yr Low
450.03
1-Year Performance
CONCORDBIO Pros and Cons
Consolidated revenue grew from ₹247 Cr in Q2 FY26 to ₹309.1 Cr in Q2 FY27 — demand recovered after Q1 FY27 dip
API revenue grew from ₹191.8 Cr in Q2 FY26 to ₹250.2 Cr in Q2 FY27 — core segment recovered after Q1 FY27 dip
Domestic revenue rose from ₹126 Cr in Q2 FY26 to ₹178.7 Cr in Q2 FY27 — local demand hit a new high
Total equity rose from ₹1,826.8 Cr in Q2 FY26 to ₹2,071.9 Cr in Q2 FY27 — balance sheet strengthened
Trade receivables eased from ₹460.2 Cr in Q4 FY26 to ₹412.5 Cr in Q2 FY27 — collections improved
EBITDA margin eased from 35.8% in Q2 FY26 to 33.8% in Q2 FY27 — profitability remains below the Q4 FY26 peak
Cash and bank balances fell from ₹19 Cr in Q2 FY26 to ₹7.7 Cr in Q2 FY27 — liquidity buffer is thinner
Inventories rose from ₹276.3 Cr in Q2 FY26 to ₹397.8 Cr in Q2 FY27 — working capital is tied up
Current liabilities rose from ₹155 Cr in Q2 FY26 to ₹201.7 Cr in Q2 FY27 — near-term obligations increased
Employee cost rose from ₹44 Cr in Q2 FY26 to ₹52.3 Cr in Q2 FY27 — cost pressure lifted in Q2 FY27
CONCORDBIO Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 3 analysts
Buy
66.67%
Hold
33.33%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
CONCORDBIO Share Price History
CONCORDBIO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
12,592
PE Ratio
44.80
PB Ratio
6.02
Dividend Yield
1.26%
ROE
12.86%
ROCE
16.70%
Book Value (₹)
99.21
Face Value (₹)
1.00
Analyse CONCORDBIO with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 44.08% | 44.08% | 44.08% | 44.08% | 44.09% |
| Domestic Institutional Investors (DII) | 9.55% | 9.58% | 9.22% | 9.36% | 10.95% |
| Foreign Institutional Investors (FII) | 8.03% | 7.58% | 7.80% | 7.52% | 7.28% |
| Public Investors | 7.77% | 8.11% | 8.09% | 8.23% | 8.81% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Concord Biotech Return Calculator
Note: Past profits do not guarantee future returns.
CONCORDBIO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
CONCORDBIO Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for CONCORDBIO
Margin on CONCORDBIO
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
CONCORDBIO Financials Summary
In Crores
CONCORDBIO Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check CONCORDBIO latest Company Filings, Investor Presentation & Conference Call details.
CONCORDBIO Revenue Growth
All values are in Crores
Revenue
Profit
Loss
CONCORDBIO Similar Stocks
FAQs on CONCORDBIO
What is the share price of Concord Biotech?
What is the 52W high and 52W low of Concord Biotech?
What is the return on Concord Biotech share?
- Past 1 year: -17.19%
- Past 3 years: -7.60%
- Past 5 years: 27.66%
What is the PE and PB Ratio of Concord Biotech?
What is the EPS of Concord Biotech?
What is the shareholding pattern of Concord Biotech?
- DIIs - 10.95%
- FII - 7.28%
- Promoters - 44.09%
- Public Investors 8.81%
- Goverenment - 0.00%
How to buy Concord Biotech shares online?
How to buy Concord Biotech shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Concord Biotech share
- Tap on “Buy”
